EDMOND DE ROTHSCHILD (SUISSE) S.A. - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 130 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD (SUISSE) S.A. ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$1,424,000
+179.8%
499,000
+232.7%
0.48%
+198.8%
Q2 2015$509,000150,0000.16%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 1,312,006$16,990,00016.50%
VHCP Management, LLC 1,000,273$12,954,0006.97%
Cormorant Asset Management, LP 1,700,000$22,015,0006.39%
HARVEY CAPITAL MANAGEMENT INC 890,500$11,531,0004.76%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 859,672$11,133,0002.50%
Rhenman & Partners Asset Management AB 400,000$5,180,0002.03%
SECTORAL ASSET MANAGEMENT INC 2,758,950$35,728,0001.54%
NORTHPOINTE CAPITAL LLC 1,289,711$16,701,0001.47%
Knoll Capital Management, LLC 200,000$2,592,0001.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,483,260$19,208,0001.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders